Outcomes of endovascular salvage of clotted arteriovenous access and predictors of patency after thrombectomy.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
04 2020
Historique:
received: 07 01 2019
accepted: 15 07 2019
pubmed: 8 9 2019
medline: 28 8 2020
entrez: 8 9 2019
Statut: ppublish

Résumé

This study aimed to report the outcomes of endovascular salvage of clotted arteriovenous (AV) accesses and to determine potential predictors of poor patency rates after thrombectomy. Records of hemodialysis patients who underwent endovascular salvage of clotted AV access were reviewed retrospectively. Technical and clinical success rates, complication rates, and 3- and 6-month patency rates were determined. Multivariate analysis was performed to determine the predictors of patency after thrombectomy. A total of 294 patients underwent endovascular salvage of clotted AV access during the study period; 156 patients had arteriovenous fistula, whereas the remaining 138 were arteriovenous grafts (AVGs). The technical and clinical success rates were 96.3% and 93.2%; the major and minor complication rates were 0.7% and 9.9%. Post-thrombectomy primary, assisted primary, and secondary patency rates were 62.9%, 76.2%, and 77.6% at 3 months and 43.9%, 59.5%, and 61.6% at 6 months. The patency rates were significantly better for arteriovenous fistula than for AVG except for 6-month assisted primary and secondary patency. Multivariate Cox regression analysis showed that prior thrombosis within 90 days was significantly associated with loss of primary patency (hazard ratio [HR], 1.90; 95% confidence interval [CI], 1.21-2.98; P < .01), assisted primary patency (HR, 2.42; 95% CI, 1.42-4.13; P < .01), and secondary patency (HR, 2.52; 95% CI, 1.40-4.53; P < .01). Having an AVG was also negatively associated with primary patency. Most clotted AV accesses can be salvaged by endovascular technique. Recurrent thrombosis within 90 days is associated with poor short- and long-term patency even after successful endovascular reinterventions.

Identifiants

pubmed: 31492611
pii: S0741-5214(19)31804-X
doi: 10.1016/j.jvs.2019.07.056
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1333-1339

Informations de copyright

Copyright © 2019 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Ru Yu Tan (RY)

Department of Renal Medicine, Singapore General Hospital, Singapore. Electronic address: tan.ru.yu@singhealth.com.sg.

Suh Chien Pang (SC)

Department of Renal Medicine, Singapore General Hospital, Singapore.

Swee Ping Teh (SP)

Department of Renal Medicine, Singapore General Hospital, Singapore.

Chee Yong Ng (CY)

Department of Renal Medicine, Singapore General Hospital, Singapore.

Kian Guan Lee (KG)

Department of Renal Medicine, Singapore General Hospital, Singapore.

Marjorie Wai Yin Foo (MWY)

Department of Renal Medicine, Singapore General Hospital, Singapore.

Apoorva Gogna (A)

Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore.

Tze Tec Chong (TT)

Department of Vascular Surgery, Singapore General Hospital, Singapore.

Chieh Suai Tan (CS)

Department of Renal Medicine, Singapore General Hospital, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH